Title:
糸球体上皮細胞関連障害及び／又はネフローゼ症候群の治療に用いるＤＰＰ−４阻害薬としてのキサンチン誘導体
Document Type and Number:
Japanese Patent JP6759373
Kind Code:
B2
Abstract:
The present invention relates to methods for treating and/or preventing podocytes related disorders and/or nephrotic syndrome comprising the administration of an effective amount of a certain DPP-4 inhibitor, in particular linagliptin, as well as to the use of a certain DPP-4 inhibitor for treating and/or preventing albuminuria or diabetic nephropathy or the onset of chronic kidney diseases.
Inventors:
Klein Thomas
Von Einatten Maximilian
Hocher Belt Holt
Marc michael
Sharkovska Yulia
Von Einatten Maximilian
Hocher Belt Holt
Marc michael
Sharkovska Yulia
Application Number:
JP2019009897A
Publication Date:
September 23, 2020
Filing Date:
January 24, 2019
Export Citation:
Assignee:
Boehringer Ingelheim International GmbH
International Classes:
A61K31/522; A61K45/00; A61P3/10; A61P13/00; A61P13/12; A61P43/00
Domestic Patent References:
| JP6473208B2 |
Attorney, Agent or Firm:
Shinichiro Tanaka
Kazuo Yamazaki
Satsuki Ichikawa
Hironobu Hattori
Kobayashi Machiko
Kazuo Yamazaki
Satsuki Ichikawa
Hironobu Hattori
Kobayashi Machiko